Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksLSAI.L Regulatory News (LSAI)

  • There is currently no data for LSAI

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Covid-19 Update

23 Mar 2020 12:00

RNS Number : 2040H
Location Sciences Group PLC
23 March 2020
 

23 March 2020

 

Location Sciences Group PLC("Location Sciences" or the "Company")

 

Covid-19 Update

 

Given the current and rapidly changing developments regarding COVID-19, Location Sciences (AIM: LSAI) provides the following update.

Ways of working

We are a virtual business, operating across four locations globally. All of our systems are in the cloud, with our normal day involving Slack stand ups and Zoom conference calls. We have all been able to adjust to working from home very easily.

Business impact

We are still very small and a large part of our revenues are repeatable licence deals. We are also heavily H2, and specifically Q4, weighted in our forecasts and business plans to take into account seasonal spikes in advertising. The market has, of course, shifted and we are living in uncertain times. In addition, as we work with location advertisers, there will be campaigns that are postponed to later dates. However, we are already seeing new campaigns being launched - for example by companies operating in the pharmaceutical sector. We continue to support our global clients and are continuing to sign new customers up.

R&D

We are an early stage business still in the research and development stage of our product. In many ways, this time allows us to invest in the important engineering work we are undertaking. We are launching an updated version of our platform at the end of April 2020. This will give our customers a clearer picture of how to obtain better value from their location spend and how to drive better performance. This will be needed in the months ahead, as companies look for a competitive edge.

Data for good

As a location data business, with billions of location events, we are exploring how we can use this data (and our data science skills) for good, or wider initiatives we would like to help wherever we can.

EGM Attendance

If you wish to attend the Company's General Meeting convened for 11.00 am on 26 March 2020 via webinar, please register in advance by following this link: https://locationsciences.zoom.us/webinar/register/WN_vNzqXAu9TZmALuHZfvwo4g. After registering, you will receive a confirmation email containing instructions on how to join.

Shareholders will not be able to vote via the webinar, so all shareholders wishing to attend on this basis must vote prior to the General Meeting by submitting a proxy vote by no later than 11.00 a.m. on 24 March 2020. Details of how to appoint a proxy are set out in the Company's circular to shareholders published on 9 March 2020 ("Circular") and available from the Company's website at https://www.locationsciencesgroup.ai/wp-content/uploads/2020/03/March-2020-Circular-and-Notice-of-General-Meeting.pdf

The General Meeting is being held to approve, amongst other things, the Resolutions related to the Company's Placing announced on 6 March 2020.

Mark Slade, Chief Executive Officer, commented "I understand that in these challenging times, communication is paramount. With that in mind, I wanted to share this update on our business operations and reassure our shareholders that their business remains on track to deliver value in 2020".

Terms used in this announcement but not otherwise defined have the meanings given to them in the Circular.

 

For further information please contact: 

 

Location Sciences Group PLC

via Milk and Honey PR

Mark Slade, Chief Executive Officer

 

David Rae, Chief Financial Officer

 

 

 

Shore Capital (Nomad and Joint Broker)

Tel: +44 (0)20 7408 4090

Tom Griffiths

 

David Coaten

 

 

 

Peterhouse Capital (Joint Broker)

Charles Goodfellow

Eran Zucker

Tel: +44 (0) 20 7220 9791

 

 

 

 

Milk & Honey PR

 Tel: +44 (0)20 3637 7310

Kirsty Leighton

 

Jessica Ballinger

 

 

The person making this notification on behalf of the Company is David Rae, Chief Financial Officer of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
UPDKKNBPDBKDANB
Date   Source Headline
18th Sep 20177:00 amRNSHalf-year Report and Trading Update
14th Sep 20176:03 pmRNSTR-1: Notification of major holdings
13th Sep 201712:40 pmRNSTR-1: Notification of major holdings
11th Sep 20177:00 amRNSLaunch of Location Sciences
6th Sep 20174:59 pmRNSTR-1: Notification of major holdings
5th Sep 20172:49 pmRNSTR-1: Notification of major holdings
29th Aug 20177:00 amRNSNew Directorship
25th Aug 20171:31 pmRNSTR-1: Notification of major holdings
24th Aug 20171:17 pmRNSTR-1: Notification of major holdings
10th Aug 20177:00 amRNSSettlement of credit facility and loan note
9th Aug 20173:00 pmRNSTR-1: Notification of major holdings
28th Jul 20173:43 pmRNSTR-1: Notification of major holdings
27th Jul 20174:04 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
24th Jul 201711:54 amRNSResult of AGM and GM
24th Jul 20177:01 amRNSAGM Statement
24th Jul 20177:00 amRNSResult of Open Offer
17th Jul 20177:00 amRNSProxama signs agreement with Rail Delivery Group
13th Jul 20177:00 amRNSContract Renewal
3rd Jul 20176:01 pmRNSHolding(s) in Company
30th Jun 201711:31 amRNSResult of Placing
30th Jun 20177:01 amRNSProposed Placing
30th Jun 20177:00 amRNSFinal Results
25th May 20177:00 amRNSNew Contracts
18th May 20177:00 amRNSBoard Changes
17th May 20177:00 amRNSConclusion of the Strategic Review
27th Apr 20171:07 pmRNSNotification of Interest In Shares
28th Mar 20172:04 pmRNSIssue of Equity and Total Voting Rights
7th Mar 20177:00 amRNSDirector Declaration
1st Mar 20174:39 pmRNSResult of General Meeting
1st Mar 20177:00 amRNSNew Contract Win
16th Feb 20177:00 amRNSAppointment of Non-Executive Chairman
13th Feb 20177:00 amRNSPosting of Circular and Notice of General Meeting
9th Feb 20173:40 pmRNSHolding(s) in Company
6th Feb 20177:00 amRNSNew Contract Win
3rd Feb 20177:00 amRNSIssue of Equity
23rd Jan 20177:00 amRNSNew Partnership
10th Jan 20177:00 amRNSBeacon network expansion
5th Jan 201710:20 amRNSTotal Voting Rights
3rd Jan 20178:00 amRNSBlock listing
21st Dec 20167:00 amRNSNew Contract
13th Dec 20167:00 amRNSTrading and Funding update
25th Nov 20167:00 amRNS'Santa Forgot' campaign for Alzheimer's Research
29th Sep 20167:00 amRNSHalf-year Report
23rd Sep 20162:55 pmRNSHolding(s) in Company
22nd Sep 20165:22 pmRNSExercise of Options
22nd Sep 20167:00 amRNSNew Contract
2nd Sep 20167:00 amRNSGoogle Certification
11th Aug 20163:24 pmRNSTR-1 Notification of Major Interest in Shares
11th Aug 20163:20 pmRNSDirector/PDMR Shareholding
27th Jul 20164:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.